BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Nexia Biotechnologies Inc. 

21,025 Trans-Canada Highway

Ste. Anne-de-Bellevue  Quebec  H9X 3V9  Canada
Phone: 514-457-4522 Fax: 514-457-6151


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Nexia Biotechnologies Inc. Announces Stock Exchange Listing, PharmAthene, Inc. Amalgamation Proposal, New BioSteel Patent And Second Quarter 2007 Results 1/22/2007 1:56:36 PM
Nexia Biotechnologies Inc. Announces Stock Exchange Listing, PharmAthene, Inc. Amalgamation Proposal, New BioSteel Patent And Second Quarter 2007 Results 1/22/2007 12:14:24 PM
Nexia Biotechnologies Inc. Arrangement Obtains Shareholder And Court Approval 10/18/2006 11:34:00 AM
Nexia Biotechnologies Inc. Completes Sale Of Protexia Operations, Assets To PharmAthene, Inc.; PharmAthene Closes $11.2 Series C10/19/2005 5:13:01 PM
Nexia Biotechnologies Inc. Announces Completion Of Sale Of All Assets Associated With Protexia(R) 10/19/2005 5:13:00 PM
PharmAthene Adds Premier Chemical Scavenger Franchise To Its Leading Biological And Chemical Defense Portfolio10/19/2005 5:12:59 PM
Nexia Biotechnologies Inc.'s Shareholders Approve Sale Of All Assets Associated With Protexia(R)10/19/2005 5:12:57 PM
Nexia Biotechnologies Inc. Second Quarter Results And Provides Corporate Update10/19/2005 5:12:50 PM
Nexia Biotechnologies Inc. Reschedules Annual General & Special Meeting To March 7, 200510/19/2005 5:12:40 PM
Nexia Biotechnologies Inc. Announces Agreement To Sell All Assets Associated With Protexia(R) To PharmAthene, Inc.10/19/2005 5:12:01 PM
12